浙山蛩抗癌作用的实验研究  

Experimental study on antineoplastic effects of Spirobolus walkeri pocock

作　　者：熊耀康 黄绳武[1] 严云良[1] 金贻郎[1] 王平 

机构地区：[1]浙江中医学院,杭州310009

出　　处：《中国现代应用药学》1998年第3期7-9,共3页Chinese Journal of Modern Applied Pharmacy

摘　　要：对浙山蛩的抗癌作用进行了研究,结果显示:浙山蛩高剂量对S_(180)实验小鼠具抑瘤作用,抑瘤率为33.63％,它还可以增强S_(180)肉瘤小鼠NK活性、明显提高T淋巴细胞的转化率并提高艾氏腹水瘤小鼠存活天数。The animal experiments have shown that the high dose of Spirobolus walkeri pocock may inhibit tumor with the inhibiting rate in 33. 63 %, enhance the activity of natural killer cell and significantly increase T lymphocyte transformation rate in mice carried Sarcoma-180,prolong the vital stage of the EAC transplanted mice.

关 键 词：浙山蛩 抗癌 T淋巴细胞 转化率 药理学 

分 类 号：R931.74[医药卫生—生药学]